MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Pseudolymphoma

(UMLS:C0221269)

Definition:: A group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma. Pseudolymphoma is characterized by a benign infiltration of lymphoid cells or histiocytes which microscopically resembles a malignant lymphoma. (From Dorland, 28th ed & Stedman, 26th ed)
UMLS ID:: C0221269
MeSH ID:: D019310

Classification:

Name:

Hemic and Lymphatic Diseases
MeSH Tree Number(s):: C15.604.613

Synonym(s)

Pseudolymphoma

Benign Lymphoid Hyperplasia

Benign lymphoid hyperplasia

LYMPHOMA LIKE REACTION

LYMPHOMA-LIKE DISORDER

Pseudolymphoma, NOS

Reactive lymphoid hyperplasia

benign lymphoid hyperplasia

hyperplasia lymphoid reactive

10.

lymphocytoma

11.

pseudo lymphoma

12.

pseudolymphoma

13.

reactive lymphoid hyperplasia

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Amlodipine	FAERS: 11		US FAERS
2	Lamotrigine	FAERS: 9		US FAERS
3	Deferasirox	FAERS: 6 Canada Vigilance: 1		Canada Vigilance US FAERS
4	Phenytoin	FAERS: 4 Canada Vigilance: 2	View details 574201 1186408 1419762 8603615 9003978 12752131	CTD SIDER Canada Vigilance US FAERS
5	Amlodipine	FAERS: 3		US FAERS
6	Carbamazepine	FAERS: 3 Canada Vigilance: 1	9591791 12752131	CTD SIDER Canada Vigilance US FAERS
7	Enalapril	FAERS: 3		US FAERS
8	Ethosuximide	FAERS: 3		US FAERS
9	Methotrexate	FAERS: 3	8572492	CTD US FAERS
10	Ramipril	FAERS: 3		US FAERS
11	Azathioprine	FAERS: 2		US FAERS
12	Fingolimod Hydrochloride	FAERS: 2		US FAERS
13	Levofloxacin	FAERS: 2		US FAERS
14	Lisinopril	FAERS: 2		SIDER US FAERS
15	Rivaroxaban	FAERS: 2		US FAERS
16	Valproic Acid	FAERS: 2	11422049 12752131	CTD US FAERS
17	Vemurafenib	FAERS: 2		US FAERS
18	hydrochlorothiazide, lisinopril drug combination	FAERS: 2		US FAERS
19	4-hydroxybutyric acid	FAERS: 1		US FAERS
20	Allopurinol	FAERS: 1		US FAERS
21	Aripiprazole	FAERS: 1		US FAERS
22	Atenolol	FAERS: 1		US FAERS
23	Atorvastatin	FAERS: 1		US FAERS
24	Bexarotene	FAERS: 1		SIDER US FAERS
25	Cefuroxime	FAERS: 1		US FAERS
26	Cyclosporine	FAERS: 1 Canada Vigilance: 2		Canada Vigilance US FAERS
27	Insulin Glargine	FAERS: 1		US FAERS
28	Isotretinoin	FAERS: 1		US FAERS
29	Levetiracetam	FAERS: 1		US FAERS
30	Losartan	FAERS: 1		US FAERS
31	Mebrofenin	FAERS: 1		US FAERS
32	Medroxyprogesterone Acetate	FAERS: 1		US FAERS
33	Methylphenidate	FAERS: 1		US FAERS
34	Methylphenidate	FAERS: 1		US FAERS
35	Minocycline	FAERS: 1		US FAERS
36	Naproxen	FAERS: 1		US FAERS
37	Octreotide	FAERS: 1		US FAERS
38	Oxcarbazepine	FAERS: 1		US FAERS
39	PCI 32765	FAERS: 1		US FAERS
40	Ranitidine	FAERS: 1		US FAERS
41	Simvastatin	FAERS: 1		US FAERS
42	Sulfasalazine	FAERS: 1		US FAERS
43	Topiramate	FAERS: 1		US FAERS
44	Ursodeoxycholic Acid	FAERS: 1		US FAERS
45	Valproic Acid	FAERS: 1		US FAERS
46	ambrisentan	FAERS: 1		US FAERS
47	Cidofovir			SIDER
48	Clomipramine			SIDER
49	Clozapine	Canada Vigilance: 2		Canada Vigilance
50	Doxorubicin			SIDER
51	Fenofibrate	Canada Vigilance: 1		Canada Vigilance
52	Fentanyl	Canada Vigilance: 1		Canada Vigilance
53	Foscarnet			SIDER
54	Gabapentin			SIDER
55	Glatiramer Acetate	Canada Vigilance: 1		Canada Vigilance
56	Mycophenolic Acid			SIDER
57	Omeprazole	Canada Vigilance: 1		Canada Vigilance
58	Phenobarbital		12752131	CTD
59	Pramipexole			SIDER
60	Pregabalin			SIDER
61	Procarbazine	Canada Vigilance: 1		Canada Vigilance
62	Quinidine	Canada Vigilance: 1		Canada Vigilance
63	Selegiline			SIDER
64	Sertraline	Canada Vigilance: 1		Canada Vigilance
65	valdecoxib			SIDER

Similar ADE(s)

	Name	Semantic Similarity
1	Adenitis	42.9%
2	Histiocytosis	42.9%
3	Lymphadenitis	42.9%
4	Lymphangitis	42.9%
5	Lymphedema	42.9%
6	Splenic Diseases	42.9%
7	Thymus Hyperplasia	42.9%
8	Lymphadenopathy	42.9%
9	Elephantiasis	31%
10	Hypersplenism	31%
11	Sarcoidosis	31%
12	Elephantiasis Nostras Verrucosa	31%
13	Lymphangiectasis, Intestinal	30.5%
14	Lymphocele	28.6%
15	Lymphoproliferative Disorders	28.6%
16	Lymphatic Abnormalities	28.6%
17	Thymus Neoplasms	27.9%
18	Lymphohistiocytosis, Hemophagocytic	25.4%
19	Erdheim-Chester Disease	25.4%
20	Granuloma	20.9%
21	Histiocytic Disorders, Malignant	20.9%
22	Splenic Infarction	20.9%
23	Splenic Neoplasms	20.9%
24	Agammaglobulinemia	20.7%
25	Mucocutaneous Lymph Node Syndrome	20.7%
26	Histiocytosis, Langerhans-Cell	20.5%
27	Tumor Lysis Syndrome	20.5%
28	Heavy Chain Disease	19.3%
29	Malignant histiocytosis	16.9%
30	Sarcoidosis, Pulmonary	16.9%
31	Histiocytic sarcoma	16.9%
32	Sezary Syndrome	16.6%
33	Infectious Mononucleosis	16.1%
34	Splenic Rupture	15.8%
35	Lymphoma	15.5%
36	Disseminated Intravascular Coagulation	15.3%
37	Protein S Deficiency	15.3%
38	Thymoma	15.1%
39	Anemia	14.3%
40	Blood Coagulation Disorders	14.3%
41	Blood Platelet Disorders	14.3%
42	Bone Marrow Diseases	14.3%
43	Hemorrhagic Disorders	14.3%
44	Leukocyte Disorders	14.3%
45	Methemoglobinemia	14.3%
46	Pancytopenia	14.3%
47	Polycythemia	14.3%
48	Sulfhemoglobinemia	14.3%
49	Thrombocythemia, Essential	14.3%
50	Thrombophilia	14.3%
51	Erythrocytosis	14.3%
52	Waldenstrom Macroglobulinemia	13.3%
53	Splenosis	12.6%
54	Hodgkin Disease	12.5%
55	Lymphoma, Non-Hodgkin	12.5%
56	Autoimmune Lymphoproliferative Syndrome	12.5%
57	Leukemia, T-Cell	12.4%
58	Leukemia, B-Cell	12.4%
59	Thrombocytosis	12.4%
60	Thrombasthenia	11.4%
61	Antithrombin III Deficiency	11.4%
62	Protein C Deficiency	11.4%
63	Eosinophilic Granuloma	11.2%
64	Hemoglobinuria, Paroxysmal	11.1%
65	Leukemoid Reaction	11.1%
66	Lymphoma, Follicular	11.1%
67	T-Cell Lymphoma	11.1%
68	Mantle cell lymphoma	11.1%
69	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	11%
70	Leukemia, Large Granular Lymphocytic	11%
71	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	11%
72	Afibrinogenemia	10.7%
73	Factor VII Deficiency	10.7%
74	Factor X Deficiency	10.7%
75	Factor XII Deficiency	10.7%
76	Hemophilia A	10.7%
77	Activated Protein C Resistance	10.7%
78	Factor II deficiency	10.7%
79	Factor VIII Deficiency	10.7%
80	Factor V deficiency	10.7%
81	Factor XI Deficiency	10.7%
82	Hypoprothrombinemias	10.7%
83	Lymphoma, T-Cell, Cutaneous	10.4%
84	Lymphoma, AIDS-Related	10.4%
85	Enteropathy-Associated T-Cell Lymphoma	10.4%
86	Primary Effusion Lymphoma	10.4%
87	Anemia, Hemolytic	10.3%
88	Anemia, Macrocytic	10.3%
89	Eosinophilia	10.3%
90	Hypoproteinemia	10.3%
91	Leukopenia	10.3%
92	Thrombocytopenia	10.3%
93	Leukostasis	10.3%
94	MYELODYSPLASTIC SYNDROME	10.3%
95	Bone Marrow Neoplasms	10.2%
96	Vitamin K Deficiency	10%
97	Mycosis Fungoides	10%
98	Lymphomatoid Papulosis	10%
99	Plasmablastic lymphoma	10%
100	Transfusion Reaction	10%
101	Composite Lymphoma	10%
102	Hypotensive Transfusion Reaction	10%
103	Polycythemia Vera	9.9%
104	Lymphangioleiomyomatosis	9.9%
105	Pregnancy Complications, Hematologic	9.5%
106	Hematologic Neoplasms	9.5%
107	Anemia, Diamond-Blackfan	9.2%
108	Primary Myelofibrosis	8.5%
109	Agranulocytosis	8.5%
110	Anemia, Megaloblastic	8.5%
111	Lymphocytosis	8.5%
112	Myelofibrosis	8.5%
113	Myeloid Metaplasia	8.5%
114	Hypoalbuminemia	8.5%
115	Hypereosinophilic syndrome	8.5%
116	bone marrow fibrosis	8.5%
117	Thrombotic Microangiopathies	8.5%
118	Lymphomatoid Granulomatosis	8.4%
119	Purpura, Thrombotic Thrombocytopenic	8%
120	Neutropenia	7.6%
121	Wiskott-Aldrich Syndrome	7.4%
122	Febrile Neutropenia	7.1%
123	Anemia, Sickle Cell	7%
124	Thalassemia	7%
125	Anemia, Neonatal	7%
126	Leukocytosis	7%
127	Paraproteinemias	7%
128	Pelger-Huet Anomaly	7%
129	Pleocytosis	7%
130	Burkitt Lymphoma	6.9%
131	Cryoglobulinemia	6.7%
132	Monoclonal Gammopathy of Undetermined Significance	6.7%
133	Hemolytic-Uremic Syndrome	6.2%
134	Autoimmune thrombocytopenia	6.1%
135	Immune thrombocytopenic purpura	6.1%
136	Sickle Cell Trait	6.1%
137	Fanconi Anemia	6%
138	Lymphopenia	5.7%
139	Atypical Hemolytic Uremic Syndrome	5.7%
140	Job Syndrome	5.6%
141	Leukemia, Myelomonocytic, Chronic	5.6%
142	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	5.6%
143	Purpura, Hyperglobulinemic	5.5%
144	Thrombocytopenic purpura	5.4%
145	Hypergammaglobulinemia	5.3%
146	Pulmonary Eosinophilia	5.1%
147	Eosinophilic Pneumonia	5.1%
148	Transfusion-Related Acute Lung Injury	5.1%
149	Ecchymosis	5.1%
150	Petechiae	5.1%
151	Purpura	5.1%
152	Leukemia, Myeloid, Chronic-Phase	4.9%
153	Anemia, Pernicious	4.9%
154	Multiple Myeloma	4.8%
155	Acute Chest Syndrome	4.4%
156	Hydrops Fetalis	4.4%
157	Eosinophilia-Myalgia Syndrome	4.3%
158	Chronic granulomatous disease	4.2%
159	Shwartzman Phenomenon	4.2%
160	Hemangioma, Cavernous	4.2%
161	Scurvy	4.1%
162	Purpura Fulminans	4.1%
163	Niemann-Pick Disease, Type C	3.9%
164	Waterhouse-Friderichsen Syndrome	3.6%
165	POEMS Syndrome	3.3%
166	Kernicterus	2.9%
167	Pseudoxanthoma Elasticum	2.1%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238